Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
29/09/26	€0.0460	-.--%	0
29/09/26	€0.0460	0.00%	0
28/09/26	€0.0460	0.00%	330
25/09/26	€0.0460	0.00%	0
24/09/26	€0.0460	0.00%	0

End-of-day quote Deutsche Boerse AG

More quotes

Real-time Estimate Tradegate 07:57:40 01/10/2026 BST			5-day change	1st Jan Change
0.0615 ^EUR	+33.70%		0.00%	+248.48%

Market Cap	144K 164K 137K 123K 232K 15.69M 235K 1.63M 629K 8.02M 614K 601K 25.72M	P/E 2021	-3.89x	P/E 2022	-53x
Enterprise Value	9.87M 11.2M 9.35M 8.44M 15.91M 1.07B 16.11M 112M 43.04M 549M 42.07M 41.16M 1.76B	EV / Sales 2021	14.1x	EV / Sales 2022	1.22x
Free-Float	100%	Yield 2021 *	-	Yield 2022	-

Markets		Quality
Deutsche Boerse AG	PA8K	End-of-day quote
OTC Markets	PAIOF	Delayed
Tradegate	PA8	Real-time
Deutsche Boerse AG	PA8	Delayed
Börse Stuttgart	PA8	Delayed
Boerse Muenchen	PA8	Real-time

3 months	-24.59%
6 months	+25.68%
Current year	+248.48%

1 week	0.05	0.05
1 month	0.05	0.05
Current year	0.01	0.23
1 year	0.01	0.23
3 years	0	4.32
5 years	0	18.94
10 years	0	36.78

Paion AG Share Price

Stocks

PA8K

DE000A3E5EG5

Biotechnology & Medical Research

Valuation: Paion AG

Chart: Paion AG

Latest news: Paion AG

Press Releases: Paion AG

News in other languages: Paion AG

Quotes and Performance

Price Extremes

Managers and Directors: Paion AG

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Tilmann Bur CEO	Chief Executive Officer	62	31/08/2023
Sebastian Werner DFI	Director of Finance/CFO	-	31/05/2022

Director	Title	Age	Since
Karin Louise Dorrepaal BRD	Director/Board Member	65	30/09/2012
Hans Tanner BRD	Director/Board Member	75	31/05/2017
Markus Guilherme Dieken BRD	Director/Board Member	-	21/05/2019

Date	Insider	Type	Main position	Quantity	% Market Cap.
27/12/22	Gregor Siebert	Buy	Director	1,121	0.0016%
12/01/21	James Phillips	Buy	Chief Executive Officer	8,500	0.0127%
08/06/20	James Phillips	Buy	Chief Executive Officer	13,158	0.0202%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PAION AG	+33.70%	0.00%	+342.31%	-98.77%	373K
WUXI APPTEC CO., LTD.	+4.16%	-0.36%	+49.37%	+94.17%	74.46B
ARGENX SE	-0.59%	+0.93%	+27.40%	+80.43%	60.14B
LONZA GROUP AG	-1.11%	-0.35%	+6.25%	+35.08%	48.15B
IQVIA HOLDINGS INC.	-0.05%	+0.37%	+41.54%	+36.65%	44.25B
REVOLUTION MEDICINES, INC.	+0.38%	+7.61%	+339.53%	+641.55%	43.99B
BEONE MEDICINES AG	+0.18%	+0.26%	+7.41%	+103.45%	41.61B
CELLTRION, INC.	-0.67%	+0.17%	+7.60%	+46.37%	29.97B
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.16%	+36.77%	+22.78%	29.31B
INSMED INCORPORATED	-1.29%	-3.55%	-20.74%	+352.04%	24.93B
Average	+0.60%	+1.38%	+83.74%	+131.37%	39.68B
Weighted average by Cap.	+0.86%	+1.53%	+59.22%	+147.48%

	2021	2022
Net sales	7.13M 8.09M 6.75M 6.1M 11.49M 776M 11.64M 80.81M 31.1M 397M 30.4M 29.73M 1.27B	33.25M 37.76M 31.5M 28.44M 53.6M 3.62B 54.29M 377M 145M 1.85B 142M 139M 5.93B
Net income	-21.79M -24.74M -20.64M -18.63M -35.12M -2.37B -35.58M -247M -95.04M -1.21B -92.9M -90.87M -3.89B	-579K -658K -549K -495K -933K -63.04M -945K -6.56M -2.53M -32.23M -2.47M -2.42M -103M
Net Debt	13.77M 15.64M 13.05M 11.78M 22.2M 1.5B 22.48M 156M 60.07M 766M 58.71M 57.43M 2.46B	9.72M 11.04M 9.21M 8.32M 15.67M 1.06B 15.88M 110M 42.42M 541M 41.46M 40.56M 1.74B